Literature DB >> 11013664

The microbial spectrum of brain abscess with special reference to anaerobic bacteria.

R Chaudhry1, B Dhawan, B V Laxmi, V S Mehta.   

Abstract

The bacteriological and clinical findings of 18 cases of brain abscess are presented. Identification and antimicrobial susceptibility of anaerobic strains was performed both by conventional methods and the newer RapID ANA II panel and E-test methods, respectively. Characterization of the anaerobic isolates was done by restriction fragment length polymorphism (RFLP). Anaerobic or aerobic organisms alone were recovered in three (16.6%), and mixed aerobic and anaerobic in another three (16.6%) patients. There were nine anaerobic isolates. The predominant anaerobes were Prevotella melaninogenicus (four isolates), Bacteroides preacutus (three isolates), Fusobacterium nucleatum and Peptostreptococcus sp. (one isolate each). A total of six aerobic isolates, all of which were Gram-positive cocci were recovered. All the anaerobic isolates were susceptible to metronidazole, but two isolates of P. melaninogenicus were resistant to penicillin. There was complete agreement between the identification based on biochemical profiles and RFLP patterns. These findings indicate the microbial complexity of brain abscess and the need to target antimicrobial therapy against both the aerobic and anaerobic components of infection.

Entities:  

Mesh:

Year:  1998        PMID: 11013664     DOI: 10.1080/02688699845258

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  11 in total

1.  Aliens, anaerobes, and the lung!

Authors:  Paul Marik
Journal:  Intensive Care Med       Date:  2003-07       Impact factor: 17.440

2.  Efficient gene transfer and targeted mutagenesis in Fusobacterium nucleatum.

Authors:  Susan Kinder Haake; Sean Yoder; Sharon Hunt Gerardo
Journal:  Plasmid       Date:  2005-08-22       Impact factor: 3.466

3.  Production of indole from L-tryptophan and effects of these compounds on biofilm formation by Fusobacterium nucleatum ATCC 25586.

Authors:  Takako Sasaki-Imamura; Akira Yano; Yasuo Yoshida
Journal:  Appl Environ Microbiol       Date:  2010-05-14       Impact factor: 4.792

4.  In vivo proton MR spectroscopy evaluation of pyogenic brain abscesses: a report of 194 cases.

Authors:  D Pal; A Bhattacharyya; M Husain; K N Prasad; C M Pandey; R K Gupta
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-01       Impact factor: 3.825

5.  Identification and characterization of a novel adhesin unique to oral fusobacteria.

Authors:  Yiping W Han; Akihiko Ikegami; Chythanya Rajanna; Hameem I Kawsar; Yun Zhou; Mei Li; Hakimuddin T Sojar; Robert J Genco; Howard K Kuramitsu; Cheri X Deng
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

6.  An unusual mechanism for brain abscess formation in a child.

Authors:  Yu-Ching Chang; Jiun-Chang Lee; Kuang-Lin Lin; Chieh-Tsai Wu; Alex Mun-Ching Wong
Journal:  Childs Nerv Syst       Date:  2009-03-25       Impact factor: 1.475

7.  Microbiological spectrum of brain abscess at a tertiary care hospital in South India: 24-year data and review.

Authors:  V Lakshmi; P Umabala; K Anuradha; K Padmaja; C Padmasree; A Rajesh; A K Purohit
Journal:  Patholog Res Int       Date:  2011-11-16

8.  Genome sequence of Fusobacterium nucleatum subspecies polymorphum - a genetically tractable fusobacterium.

Authors:  Sandor E Karpathy; Xiang Qin; Jason Gioia; Huaiyang Jiang; Yamei Liu; Joseph F Petrosino; Shailaja Yerrapragada; George E Fox; Susan Kinder Haake; George M Weinstock; Sarah K Highlander
Journal:  PLoS One       Date:  2007-08-01       Impact factor: 3.240

9.  Detection of Fusobacterium nucleatum in culture-negative brain abscess by broad-spectrum bacterial 16S rRNA Gene PCR.

Authors:  Catherine Chakvetadze; Anastasia Purcarea; Aurelia Pitsch; Jonathan Chelly; Sylvain Diamantis
Journal:  IDCases       Date:  2017-04-26

10.  Microbial aetiology of brain abscess in a UK cohort: Prominent role of Streptococcus intermedius.

Authors:  Christopher A Darlow; Nicholas McGlashan; Richard Kerr; Sarah Oakley; Pieter Pretorius; Nicola Jones; Philippa C Matthews
Journal:  J Infect       Date:  2020-03-13       Impact factor: 6.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.